These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23863473)

  • 1. Sensitive detection of melanoma metastasis using circulating microRNA expression profiles.
    Shiiyama R; Fukushima S; Jinnin M; Yamashita J; Miyashita A; Nakahara S; Kogi A; Aoi J; Masuguchi S; Inoue Y; Ihn H
    Melanoma Res; 2013 Oct; 23(5):366-72. PubMed ID: 23863473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a Circulating MicroRNA Profile as a Biomarker of Metastatic Cutaneous Melanoma.
    Armand-Labit V; Meyer N; Casanova A; Bonnabau H; Platzer V; Tournier E; Sansas B; Verdun S; Thouvenot B; Hilselberger B; Doncescu A; Lamant L; Lacroix-Triki M; Favre G; Pradines A
    Acta Derm Venereol; 2016 Jan; 96(1):29-34. PubMed ID: 26039581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased serum microRNA-206 level predicts unfavorable prognosis in patients with melanoma.
    Tian R; Liu T; Qiao L; Gao M; Li J
    Int J Clin Exp Pathol; 2015; 8(3):3097-103. PubMed ID: 26045823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of plasma microRNAs as new potential biomarkers with high diagnostic power in human cutaneous melanoma.
    Fogli S; Polini B; Carpi S; Pardini B; Naccarati A; Dubbini N; Lanza M; Breschi MC; Romanini A; Nieri P
    Tumour Biol; 2017 May; 39(5):1010428317701646. PubMed ID: 28466785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Potential of Circulating miR-193b, miR-146b-3p and miR-483-3p as Noninvasive Biomarkers in Cutaneous Melanoma Patients.
    Mohammadloo A; Asgari Y; Esmaeili-Bandboni A; Mazloomi MA; Ghasemi SF; Ameri S; Miri SR; Hamzelou S; Mahmoudi HR; Veisi-Malekshahi Z
    Mol Biotechnol; 2024 Oct; 66(10):2830-2840. PubMed ID: 37934389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
    Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
    Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patients.
    Ono S; Oyama T; Lam S; Chong K; Foshag LJ; Hoon DS
    Oncotarget; 2015 Mar; 6(9):7053-64. PubMed ID: 25749524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of miR-203 is decreased and associated with the prognosis of melanoma patients.
    Wang K; Zhang ZW
    Int J Clin Exp Pathol; 2015; 8(10):13249-54. PubMed ID: 26722525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human miR-1228 as a stable endogenous control for the quantification of circulating microRNAs in cancer patients.
    Hu J; Wang Z; Liao BY; Yu L; Gao X; Lu S; Wang S; Dai Z; Zhang X; Chen Q; Qiu SJ; Wu Y; Zhu H; Fan J; Zhou J; Wang J
    Int J Cancer; 2014 Sep; 135(5):1187-94. PubMed ID: 24488924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers.
    Powrózek T; Krawczyk P; Kowalski DM; Winiarczyk K; Olszyna-Serementa M; Milanowski J
    Transl Res; 2015 Oct; 166(4):315-23. PubMed ID: 26079400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma miR-127 and miR-218 Might Serve as Potential Biomarkers for Cervical Cancer.
    You W; Wang Y; Zheng J
    Reprod Sci; 2015 Aug; 22(8):1037-41. PubMed ID: 25701838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor biomarkers in melanoma.
    Ugurel S; Utikal J; Becker JC
    Cancer Control; 2009 Jul; 16(3):219-24. PubMed ID: 19556961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis.
    Tembe V; Schramm SJ; Stark MS; Patrick E; Jayaswal V; Tang YH; Barbour A; Hayward NK; Thompson JF; Scolyer RA; Yang YH; Mann GJ
    Pigment Cell Melanoma Res; 2015 May; 28(3):254-66. PubMed ID: 25490969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum miR-16: A Potential Biomarker for Predicting Melanoma Prognosis.
    Guo S; Guo W; Li S; Dai W; Zhang N; Zhao T; Wang H; Ma J; Yi X; Ge R; Wang G; Gao T; Li C
    J Invest Dermatol; 2016 May; 136(5):985-993. PubMed ID: 26829037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA miR-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker.
    Spiekermann M; Belge G; Winter N; Ikogho R; Balks T; Bullerdiek J; Dieckmann KP
    Andrology; 2015 Jan; 3(1):78-84. PubMed ID: 25187505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-10b is a prognostic biomarker for melanoma.
    Saldanha G; Elshaw S; Sachs P; Alharbi H; Shah P; Jothi A; Pringle JH
    Mod Pathol; 2016 Feb; 29(2):112-21. PubMed ID: 26743475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of circulating microRNA-125b levels in serum exosomes in advanced melanoma.
    Alegre E; Sanmamed MF; Rodriguez C; Carranza O; Martín-Algarra S; González A
    Arch Pathol Lab Med; 2014 Jun; 138(6):828-32. PubMed ID: 24878024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker.
    Kanemaru H; Fukushima S; Yamashita J; Honda N; Oyama R; Kakimoto A; Masuguchi S; Ishihara T; Inoue Y; Jinnin M; Ihn H
    J Dermatol Sci; 2011 Mar; 61(3):187-93. PubMed ID: 21273047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis.
    Hanniford D; Zhong J; Koetz L; Gaziel-Sovran A; Lackaye DJ; Shang S; Pavlick A; Shapiro R; Berman R; Darvishian F; Shao Y; Osman I; Hernando E
    Clin Cancer Res; 2015 Nov; 21(21):4903-12. PubMed ID: 26089374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Level Expression of microRNA-21 in Peripheral Blood Mononuclear Cells Is a Diagnostic and Prognostic Marker in Prostate Cancer.
    Huang W; Kang XL; Cen S; Wang Y; Chen X
    Genet Test Mol Biomarkers; 2015 Sep; 19(9):469-75. PubMed ID: 26247873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.